Cervantes F, Pereira A, Esteve J, Cobo F, Rozman C, Montserrat E
Servicio de Hematología, Escuela de Hematología Farreras-Valenti, Hospital Clínic i Provincial, Universidad de Barcelona.
Med Clin (Barc). 1997 Nov 15;109(17):651-5.
Idiopathic myelofibrosis (IM) is an infrequent myeloproliferative disorder with few large series published in the medical literature. Information on the characteristics of more recently diagnosed patients with IM is scarce.
The initial features, evolutive patterns and survival from 106 patients diagnosed with IM in a single institution between 1975 and 1996 were analyzed.
Median age of the series was 64 years (range: 17-89); there were 61 males and 55 females. One third of the patients were asymptomatic at IM diagnosis. The most common presenting symptoms were related to hypermetabolism, anemia and splenomegaly. A palpable spleen was noted in 85% of patients, and 66% had hepatomegaly. Anemia was the most frequent hematologic abnormality (50% of cases). Bone marrow biopsy showed cellular phase IM in 50 patients, IM without osteosclerosis in 39, and osteosclerotic IM in the remaining 17. Evolution into acute leukemia was seen in 14 patients (actuarial probability at 7 years: 20%, 95% CI: 0-40%), 8 patients developed portal hypertension, 5 liver failure without portal hypertension and 14 heart failure. With 62 patients having died, the series' median survival was 59 months (95% CI: 41-75).
IM is usually diagnosed in the old age. From the histologic point of view, a predominance of the cellular phase is observed at disease presentation. In recent years an increased proportion of patients asymptomatic at diagnosis is observed.
原发性骨髓纤维化(IM)是一种罕见的骨髓增殖性疾病,医学文献中发表的大型系列研究较少。关于近期诊断的IM患者特征的信息稀缺。
分析了1975年至1996年间在单一机构诊断为IM的106例患者的初始特征、演变模式和生存率。
该系列患者的中位年龄为64岁(范围:17 - 89岁);男性61例,女性55例。三分之一的患者在诊断为IM时无症状。最常见的首发症状与代谢亢进、贫血和脾肿大有关。85%的患者可触及脾脏,66%有肝肿大。贫血是最常见的血液学异常(50%的病例)。骨髓活检显示50例为细胞期IM,39例为无骨硬化的IM,其余17例为骨硬化性IM。14例患者演变为急性白血病(7年精算概率:20%,95%置信区间:0 - 40%),8例患者出现门静脉高压,5例无门静脉高压的肝衰竭,14例心力衰竭。62例患者死亡,该系列的中位生存期为59个月(95%置信区间:41 - 75)。
IM通常在老年时诊断。从组织学角度看,疾病呈现时细胞期占主导。近年来,诊断时无症状患者的比例有所增加。